Fitch Rates AmeriCredit Automobile Receivables Trust 2016-3; Outlook Stable

NEW YORK--(BUSINESS WIRE)-- Fitch Ratings assigns the following ratings and Outlooks to AmeriCredit Automobile Receivables Trust 2016-3 (AMCAR 2016-3):

--$221,000,000 class A-1 notes 'F1+sf';

--$325,000,000 class A-2-A notes 'AAAsf'; Outlook Stable;

--$75,000,000 class A-2-B notes 'AAAsf'; Outlook Stable;

--$323,940,000 class A-3 notes 'AAAsf'; Outlook Stable;

--$102,550,000 class B notes 'AAsf'; Outlook Stable;

--$127,320,000 class C notes 'Asf'; Outlook Stable;

--$125,190,000 class D notes 'BBBsf'; Outlook Stable;

--$33,240,000 class E notes 'NR'.

KEY RATING DRIVERS

Consistent Credit Quality: The 2016-3 pool displays consistent credit quality relative to recent pools based on the WA Fair Isaac Corp. (FICO) score and internal credit scores. Extended term contracts (60+ month loan terms) continue to account for the majority of the pool while new vehicles total 57% of the pool, higher than recent AMCAR transactions.

Increased Extended-Term Contracts: 60+ contracts represent 93.5% of the pool, the highest concentration for the platform. Furthermore, 2016-3 is the first AMCAR pool rated by Fitch to include 73-75 month contracts, at 3.2% of the pool. Performance data for these contracts is limited due to lack of seasoning. However, GM Financial offered the 73-75 month loans in this pool to obligors with stronger credit metrics. Given this fact and the small concentration in the pool, Fitch did not apply an additional stress to these loans.

Sufficient Credit Enhancement: Initial hard credit enhancement (CE) is consistent with 2016-2 but higher than recent transactions. CE for classes A, B, C, and D is 35.20%, 27.95%, 18.95%, and 10.10%, respectively. Excess spread is 7.77%, slightly increased from 2016-2 and 2016-1 (NR) but decreased from all transactions issued on the platform since 2011.

Stable Performance: Losses on GM Financial's managed portfolio and securitizations have been stable and relatively low, supported by the currently stable economy and healthy used vehicle values. Contrary to other nonprime lenders, recent vintage performance has not exhibited any notable weakness, with losses remaining stable for the 2013-2015 vintages to date. The cumulative base case loss proxy for this pool is 11.35%, up from 11.30% for 2015-4, the last Fitch-rated transaction.

Improved Corporate Health: Fitch currently rates GM and GM Financial 'BBB-' with a Positive Rating Outlook. The corporate rating and recent Outlook revision reflect the ongoing fundamental improvement in the company's core business over the past several years.

Consistent Origination/Underwriting/Servicing: AFSI demonstrates adequate abilities as originator, underwriter, and servicer as evidenced by historical portfolio and securitization performance. Fitch deems AFSI capable of adequately servicing 2016-3.

Legal Structure Integrity: The legal structure of the transaction should provide that a bankruptcy of GM Financial would not impair the timeliness of payments on the securities.

RATING SENSITIVITIES

Unanticipated increases in the frequency of defaults and loss severity on defaulted receivables could produce loss levels higher than the base case. This in turn could result in Fitch taking negative rating actions on the notes.

Fitch evaluated the sensitivity of the ratings assigned to AmeriCredit Automobile Receivables Trust 2016-3 to increased credit losses over the life of the transaction. Fitch's analysis found that the transaction displays some sensitivity to increased defaults and credit losses. This shows a potential downgrade of one or two categories under Fitch's moderate (1.5x base case loss) scenario, especially for the subordinate bonds. The notes could experience downgrades of three or more rating categories, potentially leading to distressed ratings (below 'Bsf') or possibly default, under Fitch's severe (2.5x base case loss) scenario.

USE OF THIRD-PARTY DUE DILIGENCE PURSUANT TO SEC RULE 17G-10

Fitch was provided with Form ABS Due Diligence-15E (Form 15E) as prepared by Deloitte and Touche, LLP. The third-party due diligence described in Form 15E focused on comparing or recomputing certain information with respect to 225 loans from the statistical data file. Fitch considered this information in its analysis and the findings did not have an impact on our analysis/conclusions. A copy of the ABS Due Diligence Form-15E received by Fitch in connection with this transaction may be obtained through the link contained on the bottom of this rating action commentary.

REPRESENTATIONS, WARRANTIES AND ENFORCEMENT MECHANISMS

A description of the transaction's representations, warranties and enforcement mechanisms (RW&Es) that are disclosed in the offering document and which relate to the underlying asset pool is available by accessing the appendix referenced under 'Related Research' below. The appendix also contains a comparison of these RW&Es to those Fitch considers typical for the asset class as detailed in the Special Report titled 'Representations, Warranties and Enforcement Mechanisms in Global Structured Finance Transactions,' dated May 31, 2016.

Additional information is available at www.fitchratings.com.

Applicable Criteria

Counterparty Criteria for Structured Finance and Covered Bonds (pub. 18 Jul 2016)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=884963

Criteria for Interest Rate Stresses in Structured Finance Transactions and Covered Bonds (pub. 17 May 2016)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=879815

Criteria for Servicing Continuity Risk in Structured Finance (pub. 17 Dec 2015)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=875586

Global Structured Finance Rating Criteria (pub. 27 Jun 2016)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=883130

Rating Criteria for U.S. Auto Loan ABS (pub. 21 Mar 2016)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=878723

Related Research

AmeriCredit Automobile Receivables Trust 2016-3 -- Appendix

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=885721

Additional Disclosures

Dodd-Frank Rating Information Disclosure Form

https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=1010245

ABS Due Diligence Form 15E 1

https://www.fitchratings.com/creditdesk/press_releases/content/ridf15E_frame.cfm?pr_id=1010245&flm_nm=15e_1010245_1.pdf

Solicitation Status

https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=1010245

Endorsement Policy

https://www.fitchratings.com/jsp/creditdesk/PolicyRegulation.faces?context=2&detail=31

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160811005726/en/

Fitch Ratings, Inc.
Primary Analyst
Timothy McNally
Associate Director
+1-212-908-0870
Fitch Ratings, Inc.
33 Whitehall Street
New York, NY 10004
or
Secondary Analyst
Cole MacKenzie
Analyst
+1-212-908-0830
or
Committee Chairperson
Du Trieu
Senior Director
+1-312-368-2091
or
Media Relations
Sandro Scenga, +1-212-908-0278
[email protected]

Source: Fitch Ratings

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• Kairos Pharma announces 1-for-7 reverse stock split
• Milestone Pharmaceuticals starts Phase 3 AFib-RVR trial for etripamil